Design and synthesis of novel tetralin-type OX<sub>2</sub>R-selective agonists based on conformational control

○Toshiaki Kuribayahsi

Presentation information

Oral Presentation

(A) Pharmaceutical Chemistry

[27E2-am] Synthetic compounds in drug discovery/Drug design

Mon. Mar 27, 2023 11:00 AM - 12:00 PM [Room E2]Institute for the Advancement of Higher Education: E308 (Bldg. E: 3F)

Chair: Hiroki Kakuta, Tomoya Hirano

11:24 AM - 11:36 AM

[27E2-am13S] Design and synthesis of novel tetralin-type OX₂R-selective agonists based on conformational control

○Toshiaki Kuribayahsi¹, Amezawa mao¹, Okada Takuhiro¹, Oshita Ryuuitiro¹, Yamamoto Naoshi², Nagumo Yasuyuki², Kutsumura Noriki^1,2,3, Irukayama Youko², Ishikawa Yukiko², Yanagisawa Masashi², Nagase Hiroshi¹, Saitoh Tuyoshi^2,3 (1. Tsukuba University Chemistry, 2. International Institute of Integrative Sleep Medicine, 3. Tsukuba University Humanics)

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Presentation information

[27E2-am] Synthetic compounds in drug discovery/Drug design

[27E2-am13S] Design and synthesis of novel tetralin-type OX2R-selective agonists based on conformational control

Password

[27E2-am13S] Design and synthesis of novel tetralin-type OX₂R-selective agonists based on conformational control